Aligos Therapeutics Inc (ALGS)
0.801
+0.05
(+6.80%)
USD |
NASDAQ |
Apr 22, 16:00
0.83
+0.03
(+3.62%)
After-Hours: 20:00
Aligos Therapeutics Accounts Payable (Quarterly): 2.517M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.517M |
| September 30, 2023 | 2.941M |
| June 30, 2023 | 3.241M |
| March 31, 2023 | 2.822M |
| December 31, 2022 | 4.737M |
| September 30, 2022 | 2.931M |
| June 30, 2022 | 2.762M |
| March 31, 2022 | 3.755M |
| Date | Value |
|---|---|
| December 31, 2021 | 3.015M |
| September 30, 2021 | 2.601M |
| June 30, 2021 | 1.593M |
| March 31, 2021 | 2.81M |
| December 31, 2020 | 3.313M |
| September 30, 2020 | 7.682M |
| June 30, 2020 | 3.296M |
| December 31, 2019 | 3.767M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.593M
Minimum
Jun 2021
7.682M
Maximum
Sep 2020
3.361M
Average
2.978M
Median
Accounts Payable (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | 7.416M |
| CEL-SCI Corp | 1.144M |
| AIM ImmunoTech Inc | 6.443M |
| IGC Pharma Inc | 0.648M |
| NovaBay Pharmaceuticals Inc | 1.13M |